The Claim
Overexpression of constitutively active Plk3 mutants enhances hyperosmotic stress-induced c-Jun phosphorylation and apoptosis in human corneal epithelial cells, while expression of a kinase-defective Plk3 mutant (K52R) suppresses these effects, demonstrating that Plk3 kinase activity is necessary and sufficient to drive c-Jun-mediated apoptosis under osmotic stress.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human corneal epithelial cells exposed to hyperosmotic stress, active Plk3 kinase increases c-Jun phosphorylation and cell death, while inactive Plk3 kinase prevents these changes.
See the scientific wording
Overexpression of constitutively active Plk3 mutants enhances hyperosmotic stress-induced c-Jun phosphorylation and apoptosis in human corneal epithelial cells, while expression of a kinase-defective Plk3 mutant (K52R) suppresses these effects, demonstrating that Plk3 kinase activity is necessary and sufficient to drive c-Jun-mediated apoptosis under osmotic stress.
When cells experience high salt or sugar levels, they shrink and turn on Plk3, which directly adds phosphate groups to c-Jun. This modified c-Jun turns on genes that cause the cell to die.
What the research says
1 studyScientists made corneal cells produce a super-active version of the Plk3 enzyme, and the cells died more easily under stress. When they turned off Plk3, the cells survived better. This proves Plk3’s enzyme activity directly controls cell death in this situation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.